UNSPSC 51384623: Bendazac lysine dihydrate

This classification denotes the lysine-dihydrate form of a nonsteroidal antiinflammatory drug with the molecular formula C16H14N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier G4AG71204O, chemically known as acetic acid, ((1-(phenylmethyl)-1h-indazol-3-yl)oxy)- but more generally known as bendazac, which bears US NIH Compound Identifier 2313. Bendazac most often comes in base, lysine, methyl ester, and sodium forms.

UNSPSC 51384623 Bendazac lysine dihydrate is a Commodity code that shows minimal recent state and local procurement activity aligned with its nominal scope. The single recent opportunity on record — Seminole County, Florida's IFB 60459723LAS, posted June 30, 2026 — solicits naloxone and drug deactivation systems for community health initiatives, not the pharmaceutical ingredient specified by the code. This mismatch signals that the code receives little relevant activity in state and local markets, and opportunities tagged to it may reflect miscoding rather than genuine demand for bendazac lysine dihydrate formulations.

Seminole County's naloxone procurement, due July 26, 2023, seeks 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The IFB requires electronic bid submission through the county's e-Procurement Portal, E-Verify compliance, drug-free workplace certification, and workers' compensation and commercial general liability insurance. The contract term runs two years with a one-year renewal option and includes a three-month probationary period. No explicit small-business set-asides are designated, though the procurement may be funded through FEMA, introducing Clean Air Act and Federal Water Pollution Control Act compliance requirements. The code does not support sufficient recent activity to characterize meaningful geographic spread or issuing-body patterns; state and local buyers pursuing bendazac lysine dihydrate or related pharmaceutical ingredients do not currently surface in public procurement records under this classification.